Succinylcholine, also known as suxamethonium, is a depolarizing neuromuscular blocking agent that plays a significant role in anesthesia. It is used primarily to facilitate intubation and to provide skeletal muscle relaxation during surgery. Succinylcholine is an essential component in anesthetic practice due to its unique properties and rapid onset of action. Some key aspects of its importance are:

​

1. Rapid onset and short duration: Succinylcholine has a rapid onset of action, usually taking effect within 30-60 seconds. Its short duration of action, typically lasting 5-10 minutes, allows for a quick return of spontaneous ventilation and muscle function after its administration.

2. Facilitation of intubation: Endotracheal intubation is a critical step in general anesthesia and emergency airway management. Succinylcholine provides rapid, profound muscle relaxation, making it easier for the anesthesiologist to secure the patient's airway with minimal complications.

3. Muscle relaxation during surgery: Adequate muscle relaxation is essential during various surgical procedures to facilitate optimal surgical conditions and prevent involuntary muscle movement. Succinylcholine can be used to achieve this goal in certain cases, though it is typically not used for prolonged surgeries due to its short duration of action.

​

Despite its importance, succinylcholine has some limitations and potential side effects, such as hyperkalemia, malignant hyperthermia, and the risk of anaphylaxis. These factors have led to the development and increased use of non-depolarizing neuromuscular blocking agents, which have longer durations of action and fewer side effects. Nonetheless, succinylcholine remains an essential tool in specific clinical scenarios due to its unique pharmacological properties.

​

Here are the main steps in succinylcholine's mechanism of action:

​

1. Binding to nicotinic acetylcholine receptors: Succinylcholine acts as an agonist at the nicotinic acetylcholine receptors located at the neuromuscular junction. It binds to these receptors, mimicking the effect of acetylcholine, the natural neurotransmitter responsible for muscle contraction.

2. Depolarization of the motor endplate: When succinylcholine binds to the nicotinic acetylcholine receptors, it causes an influx of sodium ions and a subsequent depolarization of the motor endplate. This depolarization leads to an initial transient fasciculation or involuntary muscle contraction.

3. Sustained receptor activation and desensitization: Unlike acetylcholine, which is rapidly hydrolyzed by acetylcholinesterase, succinylcholine remains bound to the nicotinic acetylcholine receptors for a longer period. This sustained activation causes the receptors to become desensitized and unresponsive to further stimulation by acetylcholine or succinylcholine.

4. Muscle paralysis: As the nicotinic acetylcholine receptors become desensitized and unresponsive, muscle fibers are unable to generate action potentials or contract. This leads to flaccid muscle paralysis, which typically lasts for several minutes before spontaneous recovery occurs.

5. Metabolism and recovery: Succinylcholine is eventually hydrolyzed by plasma cholinesterase (also known as pseudocholinesterase or butyrylcholinesterase), a naturally occurring enzyme in the blood. As the drug is metabolized, the nicotinic acetylcholine receptors regain their sensitivity, and normal neuromuscular transmission is restored, allowing muscle function to return.

​

​

                                                                                               Key points about Succinylcholine

 

• Composed of two acetylcholine molecules joined together.​

 

• Only depolarizing neuromuscular blocking agent in clinical use.

 

• Sustained depolarization causes muscle paralysis.

 

• Undergoes rapid hydrolysis by plasma cholinesterase.

 

• Only a small fraction of administered dose reaches neuromuscular junction because of metabolism by plasma cholinesterase.

 

• It does not produce analgesia, amnesia, or sedation.

 

• Quick onset and shortest duration of action.

 

• Unpredictable cardiovascular responses.

 

• Increased intravascular, intraocular, and intracranial pressure.

 

• Adverse effects: May produce fasciculations, myalgias, hyperkalemia, myoglobinuria.

 

• Triggering agent of malignant hyperthermia.

​